3020B |
Methylphenidate and Metabolite, Blood |
3020SP |
Methylphenidate and Metabolite, Serum/Plasma |
3020TI |
Methylphenidate and Metabolite, Tissue |
3020U |
Methylphenidate and Metabolite, Urine |
3045B |
Modafinil / Armodafinil, Blood |
3045SP |
Modafinil / Armodafinil, Serum/Plasma |
3057B |
Midazolam, Blood |
3057FL |
Midazolam, Fluid |
3057SP |
Midazolam, Serum/Plasma |
3057U |
Midazolam as Metabolite, Urine |
3150B |
Nicotine and Metabolite, Blood |
3150FL |
Nicotine and Metabolite, Fluid |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3150TI |
Nicotine and Metabolite, Tissue |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3175B |
Nitrazepam and Metabolite, Blood |
3175SP |
Nitrazepam and Metabolite, Serum/Plasma |
3175U |
Nitrazepam and Metabolite, Urine |
3410B |
Pentobarbital, Blood |
3410SP |
Pentobarbital, Serum/Plasma |
3410U |
Pentobarbital, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |